New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis

Details for Australian Patent Application No. 2006267976 (hide)

Owner Pfizer Limited

Inventors Kerry, Roger; Burgess, Gary Craig

Agent Spruson & Ferguson

Pub. Number AU-B-2006267976

PCT Pub. Number WO2007/007162

Priority 60/698,561 11.07.05 US

Filing date 3 July 2006

Wipo publication date 18 January 2007

Acceptance publication date 24 December 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/007162 Priority application(s): WO2007/007162

24 December 2009 Application Accepted

  Published as AU-B-2006267976

22 April 2010 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006267979-Infrared imaging spectroscopy system and method for sorting particulate material

2006267968-Novel phage display technologies